Zeguang Ren
Beijing Tiantan Hospital · Houston Methodist, Houston, USA · The Affiliated Hospital Of Guizhou Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zeguang Ren as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:28 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07670065 · Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke UnitBeijing Tiantan Hospital · not yet recruiting · Acute Ischemic Stroke, Large Vessel Occlusion · study director
- Ph4NCT07642427 · Early Prophylactic Aspirin for Aneurysmal Subarachnoid HemorrhageGanzhou City People's Hospital · not yet recruiting · Aneurysmal Subarachnoid Hemorrhage (aSAH), Delayed Cerebral Ischemia · principal investigator
- N/ANCT07633067 · Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine.The Affiliated Hospital Of Guizhou Medical University · not yet recruiting · Migraine · study chair
- N/ANCT07625449 · Early Lumbar Drainage for Intraventricular HemorrhageSecond Affiliated Hospital of Nanchang University · not yet recruiting · Intraventricular Hemorrhage, Cerebral Hemorrhage · principal investigator
- N/ANCT07456228 · Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)Beijing Tiantan Hospital · not yet recruiting · Acute Ischemic Stroke · study director
- N/ANCT06329635 · Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT TrialThe Affiliated Hospital Of Guizhou Medical University · recruiting · Aneurysmal Subarachnoid Hemorrhage, Vasospasm · principal investigator
- N/ANCT06029153 · Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable MigraineThe Affiliated Hospital Of Guizhou Medical University · completed · Migraine · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:28 UTC. The ranking covers the 200 most relevant of 152 PubMed records, and a shared surname and initials can bring in a namesake. All 152 on PubMed
- 1,719 citationsRCR 75.1
- 1,063 citationsRCR 99.5
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.Lancet Oncol · 20211,003 citationsRCR 54.5
- Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.N Engl J Med · 2023818 citationsRCR 112.1
- 694 citationsRCR 61.8
- Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial.Lancet Oncol · 2020513 citationsRCR 20.5
- Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial.Clin Cancer Res · 2021506 citationsRCR 27.5
- Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Lancet Oncol · 2023433 citationsRCR 38.6
- 363 citationsRCR 20.1
- 320 citationsRCR 84.1